flumatinib: Clinical Trials

2 trials of flumatinib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1

Follow flumatinib: new trials by email Literature Review of flumatinib trials Research Report on flumatinib

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Azacitidine,Venetoclax,and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients
Azacitidine, Venetoclax, Flumatinib - Philadelphia Chromosome, Acute Myeloid Leukemia
Phase 2CompletedThe First Affiliated Hospital of Soochow University202022-05-012024-04-25
A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
flumatinib, imatinib - Myelogenous Leukemia, Chronic
Phase 2UnknownJiangsu HengRui Medicine Co., Ltd.1502011-08-012013-04-10

Conditions studied

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Myeloid (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Philadelphia Chromosome (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

Jiangsu HengRui Medicine Co., Ltd. (1)  ·  The First Affiliated Hospital of Soochow University (1)

Countries

China (2)

Top investigators

Fengkui Zhang, Dr. (1)  ·  Jianxiang Wang, Dr. (1)  ·  Xiaowen Tang, Ph.D (1)